Condensed Consolidated Statements of Stockholders' Equity - USD ($) shares in Thousands, $ in Thousands | Total | Preferred Stock | Common Stock | Additional Paid-In Capital | Retained Earnings | Treasury Stock |
Beginning balance (in shares) at Dec. 31, 2020 | | 0 | | | | |
Beginning balance at Dec. 31, 2020 | $ 251,544 | $ 0 | $ 133 | $ 112,615 | $ 139,286 | $ (490) |
Beginning balance (in shares) at Dec. 31, 2020 | | | 13,296 | | | |
Beginning balance (in shares) at Dec. 31, 2020 | | | | | | 38 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | |
Issuance of restricted stock (in shares) | | | 62 | | | |
Compensation expense on restricted common stock | 474 | | $ 1 | 473 | | |
Taxes paid related to net shares settlement of equity awards | (224) | | | (224) | | |
Net income (loss) | (394) | | | | (394) | |
Ending balance (in shares) at Mar. 31, 2021 | | 0 | | | | |
Ending balance at Mar. 31, 2021 | 251,400 | $ 0 | $ 134 | 112,864 | 138,892 | $ (490) |
Ending balance (in shares) at Mar. 31, 2021 | | | 13,358 | | | |
Ending balance (in shares) at Mar. 31, 2021 | | | | | | 38 |
Beginning balance (in shares) at Dec. 31, 2020 | | 0 | | | | |
Beginning balance at Dec. 31, 2020 | 251,544 | $ 0 | $ 133 | 112,615 | 139,286 | $ (490) |
Beginning balance (in shares) at Dec. 31, 2020 | | | 13,296 | | | |
Beginning balance (in shares) at Dec. 31, 2020 | | | | | | 38 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | |
Net income (loss) | (3,569) | | | | | |
Ending balance (in shares) at Sep. 30, 2021 | | 0 | | | | |
Ending balance at Sep. 30, 2021 | 244,525 | $ 0 | $ 134 | 113,596 | 135,717 | $ (4,922) |
Ending balance (in shares) at Sep. 30, 2021 | | | 13,394 | | | |
Ending balance (in shares) at Sep. 30, 2021 | | | | | | 471 |
Beginning balance (in shares) at Mar. 31, 2021 | | 0 | | | | |
Beginning balance at Mar. 31, 2021 | 251,400 | $ 0 | $ 134 | 112,864 | 138,892 | $ (490) |
Beginning balance (in shares) at Mar. 31, 2021 | | | 13,358 | | | |
Beginning balance (in shares) at Mar. 31, 2021 | | | | | | 38 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | |
Issuance of restricted stock (in shares) | | | 36 | | | |
Compensation expense on restricted common stock | 421 | | | 421 | | |
Taxes paid related to net shares settlement of equity awards | (110) | | | (110) | | |
Purchase of treasury shares (in shares) | | | | | | 175 |
Purchase of treasury shares | (1,892) | | | | | $ (1,892) |
Net income (loss) | (1,918) | | | | (1,918) | |
Ending balance (in shares) at Jun. 30, 2021 | | 0 | | | | |
Ending balance at Jun. 30, 2021 | 247,901 | $ 0 | $ 134 | 113,175 | 136,974 | $ (2,382) |
Ending balance (in shares) at Jun. 30, 2021 | | | 13,394 | | | |
Ending balance (in shares) at Jun. 30, 2021 | | | | | | 213 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | |
Compensation expense on common stock options | 421 | | | 421 | | |
Purchase of treasury shares (in shares) | | | | | | 258 |
Purchase of treasury shares | (2,540) | | | | | $ (2,540) |
Net income (loss) | (1,257) | | | | (1,257) | |
Ending balance (in shares) at Sep. 30, 2021 | | 0 | | | | |
Ending balance at Sep. 30, 2021 | $ 244,525 | $ 0 | $ 134 | 113,596 | 135,717 | $ (4,922) |
Ending balance (in shares) at Sep. 30, 2021 | | | 13,394 | | | |
Ending balance (in shares) at Sep. 30, 2021 | | | | | | 471 |
Beginning balance (in shares) at Dec. 31, 2021 | 0 | 0 | | | | |
Beginning balance at Dec. 31, 2021 | $ 235,910 | $ 0 | $ 134 | 114,017 | 130,103 | $ (8,344) |
Beginning balance (in shares) at Dec. 31, 2021 | | | 13,394 | | | |
Beginning balance (in shares) at Dec. 31, 2021 | 775 | | | | | 775 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | |
Compensation expense on common stock options | $ 21 | | | 21 | | |
Issuance of restricted stock (in shares) | | | 79 | | | |
Compensation expense on restricted common stock | 402 | | $ 1 | 401 | | |
Taxes paid related to net shares settlement of equity awards | (359) | | | (359) | | |
Purchase of treasury shares (in shares) | | | | | | 247 |
Purchase of treasury shares | (2,928) | | | | | $ (2,928) |
Net income (loss) | 337 | | | | 337 | |
Ending balance (in shares) at Mar. 31, 2022 | | 0 | | | | |
Ending balance at Mar. 31, 2022 | $ 233,383 | $ 0 | $ 135 | 114,080 | 130,440 | $ (11,272) |
Ending balance (in shares) at Mar. 31, 2022 | | | 13,473 | | | |
Ending balance (in shares) at Mar. 31, 2022 | | | | | | 1,022 |
Beginning balance (in shares) at Dec. 31, 2021 | 0 | 0 | | | | |
Beginning balance at Dec. 31, 2021 | $ 235,910 | $ 0 | $ 134 | 114,017 | 130,103 | $ (8,344) |
Beginning balance (in shares) at Dec. 31, 2021 | | | 13,394 | | | |
Beginning balance (in shares) at Dec. 31, 2021 | 775 | | | | | 775 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | |
Net income (loss) | $ 187 | | | | | |
Ending balance (in shares) at Sep. 30, 2022 | 0 | 0 | | | | |
Ending balance at Sep. 30, 2022 | $ 230,259 | $ 0 | $ 135 | 114,838 | 130,290 | $ (15,004) |
Ending balance (in shares) at Sep. 30, 2022 | | | 13,499 | | | |
Ending balance (in shares) at Sep. 30, 2022 | 1,310 | | | | | 1,310 |
Beginning balance (in shares) at Mar. 31, 2022 | | 0 | | | | |
Beginning balance at Mar. 31, 2022 | $ 233,383 | $ 0 | $ 135 | 114,080 | 130,440 | $ (11,272) |
Beginning balance (in shares) at Mar. 31, 2022 | | | 13,473 | | | |
Beginning balance (in shares) at Mar. 31, 2022 | | | | | | 1,022 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | |
Compensation expense on common stock options | 147 | | | 147 | | |
Issuance of restricted stock (in shares) | | | 26 | | | |
Compensation expense on restricted common stock | 184 | | | 184 | | |
Taxes paid related to net shares settlement of equity awards | (156) | | | (156) | | |
Purchase of treasury shares (in shares) | | | | | | 288 |
Purchase of treasury shares | (3,732) | | | | | $ (3,732) |
Net income (loss) | (70) | | | | (70) | |
Ending balance (in shares) at Jun. 30, 2022 | | 0 | | | | |
Ending balance at Jun. 30, 2022 | 229,756 | $ 0 | $ 135 | 114,255 | 130,370 | $ (15,004) |
Ending balance (in shares) at Jun. 30, 2022 | | | 13,499 | | | |
Ending balance (in shares) at Jun. 30, 2022 | | | | | | 1,310 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | |
Compensation expense on common stock options | 193 | | | 193 | | |
Compensation expense on restricted common stock | 390 | | | 390 | | |
Net income (loss) | $ (80) | | | | (80) | |
Ending balance (in shares) at Sep. 30, 2022 | 0 | 0 | | | | |
Ending balance at Sep. 30, 2022 | $ 230,259 | $ 0 | $ 135 | $ 114,838 | $ 130,290 | $ (15,004) |
Ending balance (in shares) at Sep. 30, 2022 | | | 13,499 | | | |
Ending balance (in shares) at Sep. 30, 2022 | 1,310 | | | | | 1,310 |